Papillary urothelial neoplasms of low malignant potential: Clinical and biologic implications

Cancer

Volumn 86, Issue 10, 1999, Pages 2102-2108

  Cheng, Liang ^a   Neumann, Roxann M ^b   Bostwick, David G ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c BOSTWICK LABORATORIES   (United States)

Author keywords

Bladder cancer; Grading; Low grade; Low malignant potential; Natural history; Papillary urothelial carcinoma; Papillary urothelial neoplasms; Prognosis; Staging; Transitional cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CYSTOSCOPY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 0033570963     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.0.CO;2-U     Document Type: Article

References (24)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22: 1435-48.
2. Mostofi FK, Davis CJ. WHO Histological Typing of Urinary Bladder Tumors. Berlin: Springer, 1999.
3. Cheng L, Darson M, Cheville JC, Neumann RM, Zincke H, Nehra A, et al. Urothelial papilloma of the bladder: clinical and biologic implications. Cancer 1999;86:2098-101.
4. Fleming ID, Coper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. American Joint Committee on Cancer. Cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven, 1997.
5. Bostwick DG. Natural history of early bladder cancer. J Cell Biochem 1992;161:31-8.
6. Lynch CF, Platz CE, Jones MP, Gazzaniga JM. Cancer registry problems in classifying invasive bladder cancer. J Natl Cancer Inst 1991;83:429-33.
7. Hankey BF, Edwards BK, Ries LA, Percy CL, Shambaugh E. Problems in cancer surveillance: delineating in situ and invasive bladder cancer. J Natl Cancer Inst 1991;83:384-485.
8. Cheng L, Cheville JC, Neumann RM, Bostwick DG. Natural history of urothelial dysplasia. Am J Surg Pathol 1999;23: 443-7.
9. Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999;85:2469-74.
10. Holmang S, Hedelin H, Anderstrom C, Johansson SL. The relationship among multiple recurrences: progression and prognosis of patients with stages TA and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823-7.
11. Greene IF, Hanash KA, Farrow GM. Benign papilloma or papillary carcinoma of the bladder? J Urol 1973;110:205-7.
12. Malmstrom P, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987; 21:185-95.
13. Prout GR, Barton BA, Griffin PP, Friedell GH. Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol 1992;148:1413-9.
14. England HR, Paris MI, Blandy IP. The correlation of T1 bladder tumour history with prognosis and follow-up requirements. J Urol 1981;53:593-7.
15. Pocock RD, Ponder BAJ, O'Sullivan JP, Ibrahim SK, Easton DF, Shearer RJ. Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report. J Urol 1982;54: 711-5.
16. Gilbert HA, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, et al. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J Urol 1978; 119:488-92.
17. Jordan AM, Weingarten MA, Murphy WM. Transitional cell neoplasmss of the urinary bladder: can biologic potential be predicted from histologic grading? Cancer 1987;60:2766-74.
18. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
19. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986;135:920-2.
20. Fitzpatrick JM. Superficial bladder carcinoma. World J Urol 1993;11:142-7.
21. Prout GR, Bassil B, Griffin P. The treated histories of patients with Ta grade 1 transitional cell carcinoma of the bladder. Arch Surg 1986;121:1463-8.
22. Hemstreet GP, Rollins S, Jones P, Rao JY, Hurst RE, Bonner RB, et al. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid poloidy analysis of tumor tissue. J Urol 1991;146:1525-9.
23. Mufti GR, Virdi JS, Singh M. "Solitary" Ta-T1 G1 bladder tumour: history and long-term prognosis. Eur Urol 1990;18: 101-6.
24. Page BH, Levision VB, Curwen MP. The site of recurrence of non-infiltrating bladder tumors. Br J Urol 1978;50:237-42.